glp 1 drugs india Since the patent for semaglutide, the key ingredient in weight loss drugs, expired in March, prices in have fallen 80%. The country's GLP-1 market has expanded by a factor of ten in just one GLP-1 gold rush under scanner:

One notable finding from meta-analyses: cagrilintide demonstrated the lowest odds ratios for nausea, vomiting, and diarrhea when compared to other incretin-based therapies including semaglutide and tirzepatide

1,2 Consider using other histamine blockers (e.g., famotidine) or proton pump inhibitors (e.g., omeprazole, esomeprazole, lansoprazole) not shown to cause false-positives

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy

That is a statistically significant difference, but the magnitude of weight loss is modest by any standard